Digital Polymerase Chain Reaction Market - Global Industry Analysis

Digital Polymerase Chain Reaction Market By Technologies (Droplet Digital PCR, Chip Based Digital PCR, and BEAMing Digital PCR), By Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), By Application (Research, Clinical Diagnostics, and Forensic), By End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 10-Mar-2022 Category: Medical Device Report Format : PDF Pages: 149 Report Code: ZMR-6941 Status : Published

The market was valued at $143 million in 2021 and is likely to reach $312 million by the end of 2028. The market is set to experience a high growth rate of 9.3 % during the forecast period.

Description

Industry Perspective:

The market was valued at $143 million in 2021 and is likely to reach $312 million by the end of 2028. The market is set to experience a high growth rate of 9.3 % during the forecast period. The report presents comprehensive projections on the growth factors, opportunities, and restraining factors. The report also focuses on key aspects like product type, leading regions, and competitive landscape to highlight the key industry developments in the market.

Digital Polymerase Chain Reaction Market: Overview

Digital PCR is a laboratory technique used to produce a number of copies of specific pieces of DNA from samples consisting of small amounts of DNA. PCR permits pieces of DNA to be amplified for the detection process. Additionally, it is a highly sensitive quantification of nucleic acid, which is very precise. Furthermore, it is used for the absolute analysis of minority sequences and quantification. This PCR method does not rely on the quantification of sample targets. This type of PCR can detect rare events like single-nucleotide mutation, particularly of wild-type sequences in the samples. It is considered a crucial tool in patient monitoring, personalized treatment, diagnosis, cancer studies, and follow-up management.

Global Digital Polymerase Chain Reaction Market

COVID-19 Impact:

The outbreak of the Covid-19 pandemic has expedited the requirement of such a highly sensitive molecular diagnosis. This has significantly lowered the false-negative reverse transcription PCR results. After the outbreak of such a severe pandemic, there has been a significant spike in research published on the advantages of dPCR over qPCR in testing Covid cases. There is a growing demand for dPCR systems due to the range of factors like lack of innovations from sample types, higher sensitivity of dPCR, and ease in the understanding of the result. It helps in detecting Covid infections more accurately and severely than the current artificial technique. This is the first six-color dPCR instrument globally. This instrument further grows the multiplexing ability of the company's platform. Therefore, the emerging landscape is likely to positively impact the future growth trajectory of the global digital polymerase chain reaction market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Digital Polymerase Chain Reaction Market: Growth Drivers

Transformation to chip-based digital PCR from traditional droplets-based tests will boost growth of global market.

There is a significant shift from droplet to chip-based dPCR diagnosis of a wide range of diseases. Such advancements in the field of digital PCR devices are likely to drive the growth of the global digital polymerase chain reaction market exponentially in the forthcoming years. Furthermore, in the commercially operating droplet dPCR, the droplets need to be transferred manually, which leads to the target underestimation. Also, such kits pose a risk of cross-contamination while detecting the samples. On the other hand, the droplets run through channels in the chipset digital polymerase chain reaction that involves a lower risk of cross-contamination, thereby propelling its demand. Innovation is likely to fuel the adoption of chip-based digital PCR for the diagnosis of a wide range of diseases in the coming years.

Digital Polymerase Chain Reaction Market: Restraints

Expensive digital PCR devices are likely to hamper the growth of the global market.

There is a global spike in the incidences of infectious diseases, genetic disorders, and cancer among populations. But still, there is a low adoption rate of digital polymer chain reaction techniques due to the high cost of available digital PCR devices in the market.

Digital Polymerase Chain Reaction Market: Opportunities

Growing applications of digital PCR in veterinary and microbiological sciences are likely to open several new avenues in the global market.

The global digital polymerase chain reaction market is expected to witness a significant opportunistic focus due to the large-scale utilization of novel applications in laboratories. There is growing adoption of these techniques, particularly in veterinary and microbiology sciences, which in turn is likely to create huge opportunities in the forthcoming years. Furthermore, the automation of advanced instruments has powered healthcare professionals and scientists to detect genetic samples with quantitative accuracy at a lower cost. Apart from this, lesser hands-on involvement during the sample detection is likely to increase the quality of output, reduce foreign contamination, and save time.

Digital Polymerase Chain Reaction Market: Challenges

Lack of awareness among people is a huge challenge in the global market.

Despite the growing incidences of chronic illness among people globally, there is comparatively lesser demand for digital PCR due to the lack of awareness among people, which in turn is likely to emerge as a huge challenge in the global marketplace.

Digital Polymerase Chain Reaction Market: Segmentation

The global digital polymerase chain reaction market can be segmented into end-user, application, product type, technology, and region.

By technology, the market can be segmented into BEAMing digital PCR, chip-based digital PCR, and droplet digital PCR.

By product type, the market can be segmented into software & services, consumables & reagents, and digital PCR systems. The software & services segment accounts for the largest share in the global market due to the fact that it helps in enhancing the efficiency of management of digital PCR, thereby propelling the demand in the market.

By application, the market can be segmented into forensic, clinical, diagnostic, research, and others.

By end-user, the market can be segmented into universities, clinical diagnostic laboratories, pharmaceutical & biotechnology industry, and others.

Recent Developments

  • QIAGEN, in January 2021, announced the launch of a dPCR platform "Qiacity" for wastewater and mutation testing. It will help enhance its product portfolio of COVID-19 testing solutions.
  • BioMerieux SA in 2020 got the approval for Sars COV-2 gene tests that include saliva specimens.

Digital Polymerase Chain Reaction Market: Regional Landscape

North America accounts for the largest share in the global digital polymerase chain reaction market due to the presence of well-established healthcare infrastructure in the region. Furthermore, the presence of leading molecular diagnostic and associated manufacturers in the region will further propel the growth of the regional market.

Asia Pacific is likely to grow with a high CAGR in the global market during the forecast period due to the growing number of patients suffering from chronic and infectious diseases.

Digital Polymerase Chain Reaction Market: Competitive Landscape

Some of the significant players in the global digital polymerase chain reaction market include STILLA, JN Medsys, Formulatrix, Inc, Fluidigm Corp, Thermo Fisher Scientific Inc., Agilent Technologies, and Bio-Rad Laboratories, Inc.

Global digital polymerase chain reaction market is segmented as follows:

By Technology

  • Droplet Digital PCR
  • Chip Based Digital PCR
  • BEAMing Digital PCR

By Product Type

  • Digital PCR Systems
  • Consumables & Reagents
  • Software & Services

By Application

  • Research
  • Clinical Diagnostics
  • Forensic

By End User

  • Pharmaceuticals & Biotechnology Industries
  • Clinical Diagnostic Laboratories
  • Universities

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

Table Of Content

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

There is a significant shift from droplet to chip-based dPCR diagnosis of a wide range of diseases. Such advancements in the field of digital PCR devices are likely to drive the growth of the global digital polymerase chain reaction market exponentially in the forthcoming years.

The market was valued at $143 million in 2021 and is likely to reach $312 million by the end of 2028. The market is set to experience a high growth rate of 9.3 % during the forecast period.

Some of the significant players in the global digital polymerase chain reaction market includes STILLA, JN Medsys, Formulatrix, Inc, Fluidigm Corp, Thermo Fisher Scientific Inc., Agilent Technologies, and Bio-Rad Laboratories, Inc.

North America accounts for the largest share in the global digital polymerase chain reaction market due to the presence of well-established healthcare infrastructure in the region. Furthermore, the presence of leading molecular diagnostic and associated manufacturers in the region will further propel the growth of the regional market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed